Financials Medinova Diagnostic Services Limited
Equities
MEDINOV6
INE047C01019
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.08 INR | +0.52% | +3.40% | -23.01% |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 216.6 | 260 | 141.9 | 228.6 | 315.4 | 175.2 |
Enterprise Value (EV) 1 | 288.1 | 323.8 | 196.3 | 266.2 | 366.2 | 224.9 |
P/E ratio | -47.8 x | 31.6 x | -62.3 x | 11.3 x | 13.9 x | 10.5 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 2.5 x | 2.87 x | 1.89 x | 1.79 x | 2.39 x | 1.75 x |
EV / Revenue | 3.32 x | 3.58 x | 2.61 x | 2.09 x | 2.77 x | 2.25 x |
EV / EBITDA | 39.3 x | 23 x | 15.5 x | 8.86 x | 9.89 x | 8.66 x |
EV / FCF | -52.7 x | -109 x | 16.9 x | 28.1 x | 390 x | -162 x |
FCF Yield | -1.9% | -0.92% | 5.93% | 3.56% | 0.26% | -0.62% |
Price to Book | -2.18 x | -2.92 x | -1.55 x | -3.18 x | -4.63 x | -3.41 x |
Nbr of stocks (in thousands) | 9,982 | 9,982 | 9,982 | 9,982 | 9,982 | 9,982 |
Reference price 2 | 21.70 | 26.05 | 14.22 | 22.90 | 31.60 | 17.55 |
Announcement Date | 04/09/18 | 03/09/19 | 02/09/20 | 12/07/21 | 06/07/22 | 25/08/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 86.72 | 90.47 | 75.16 | 127.4 | 132 | 99.93 |
EBITDA 1 | 7.34 | 14.08 | 12.64 | 30.05 | 37.04 | 25.98 |
EBIT 1 | -11.5 | 1.229 | 3.134 | 22.89 | 31.6 | 22.74 |
Operating Margin | -13.26% | 1.36% | 4.17% | 17.96% | 23.94% | 22.76% |
Earnings before Tax (EBT) 1 | -5.151 | 10.89 | -2.757 | 19.62 | 27.97 | 19 |
Net income 1 | -4.532 | 8.229 | -2.277 | 20.22 | 22.68 | 16.65 |
Net margin | -5.23% | 9.1% | -3.03% | 15.87% | 17.18% | 16.66% |
EPS 2 | -0.4540 | 0.8244 | -0.2281 | 2.026 | 2.270 | 1.668 |
Free Cash Flow 1 | -5.47 | -2.967 | 11.63 | 9.474 | 0.9386 | -1.385 |
FCF margin | -6.31% | -3.28% | 15.47% | 7.43% | 0.71% | -1.39% |
FCF Conversion (EBITDA) | - | - | 91.98% | 31.53% | 2.53% | - |
FCF Conversion (Net income) | - | - | - | 46.85% | 4.14% | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 04/09/18 | 03/09/19 | 02/09/20 | 12/07/21 | 06/07/22 | 25/08/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 71.5 | 63.7 | 54.3 | 37.6 | 50.7 | 49.7 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 9.747 x | 4.527 x | 4.296 x | 1.251 x | 1.37 x | 1.913 x |
Free Cash Flow 1 | -5.47 | -2.97 | 11.6 | 9.47 | 0.94 | -1.39 |
ROE (net income / shareholders' equity) | 4.65% | -8.63% | 2.46% | -22.6% | -33.3% | -27.9% |
ROA (Net income/ Total Assets) | -9.8% | 1.42% | 4.44% | 33.9% | 44.8% | 31.9% |
Assets 1 | 46.26 | 581.2 | -51.33 | 59.6 | 50.61 | 52.24 |
Book Value Per Share 2 | -9.960 | -8.930 | -9.190 | -7.210 | -6.820 | -5.150 |
Cash Flow per Share 2 | 0.1100 | 0.0600 | 0.2100 | 0.3200 | 0.5600 | 0.7800 |
Capex 1 | 1.33 | 1.57 | 0.23 | 1.85 | 1.69 | 3.87 |
Capex / Sales | 1.53% | 1.74% | 0.3% | 1.45% | 1.28% | 3.87% |
Announcement Date | 04/09/18 | 03/09/19 | 02/09/20 | 12/07/21 | 06/07/22 | 25/08/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-23.01% | 44.1L | |
+24.66% | 8.84TCr | |
-21.76% | 7.76TCr | |
+9.01% | 2.87TCr | |
+7.41% | 1.84TCr | |
-13.50% | 1.66TCr | |
+77.51% | 1.37TCr | |
+76.96% | 1.31TCr | |
+4.53% | 1.26TCr | |
+36.67% | 1.26TCr |
- Stock Market
- Equities
- MEDINOV6 Stock
- Financials Medinova Diagnostic Services Limited